Plasma metabolomic profiles associated with mortality and longevity in a prospective analysis of 13,512 individuals

Identificador:  imarina:9329936

Handle: https://hdl.handle.net/20.500.11797/imarina9329936

Autores:  Wang, Fenglei; Tessier, Anne-Julie; Liang, Liming; Wittenbecher, Clemens; Haslam, Danielle E; Fernandez-Duval, Gonzalo; Heather Eliassen, A; Rexrode, Kathryn M; Tobias, Deirdre K; Li, Jun; Zeleznik, Oana; Grodstein, Francine; Martinez-Gonzalez, Miguel A; Salas-Salvado, Jordi; Clish, Clary; Lee, Kyu Ha; Sun, Qi; Stampfer, Meir J; Hu, Frank B; Guasch-Ferre, Marta

Resumen:
Experimental studies reported biochemical actions underpinning aging processes and mortality, but the relevant metabolic alterations in humans are not well understood. Here we examine the associations of 243 plasma metabolites with mortality and longevity (attaining age 85 years) in 11,634 US (median follow-up of 22.6 years, with 4288 deaths) and 1878 Spanish participants (median follow-up of 14.5 years, with 525 deaths). We find that, higher levels of N2,N2-dimethylguanosine, pseudouridine, N4-acetylcytidine, 4-acetamidobutanoic acid, N1-acetylspermidine, and lipids with fewer double bonds are associated with increased risk of all-cause mortality and reduced odds of longevity; whereas L-serine and lipids with more double bonds are associated with lower mortality risk and a higher likelihood of longevity. We further develop a multi-metabolite profile score that is associated with higher mortality risk. Our findings suggest that differences in levels of nucleosides, amino acids, and several lipid subclasses can predict mortality. The underlying mechanisms remain to be determined.© 2023. Springer Nature Limited.